Mevalonic acid

Mevalonic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 10134 references associated with Mevalonic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Mevalonic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Mevalonic acid

MeSH term MeSH ID Detail
Cell Transformation, Neoplastic D002471 126 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Adenocarcinoma D000230 166 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 | Total 25

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with Mevalonic acid

Download all related citations
Per page 10 20 50 100 | Total 2899
Authors Title Published Journal PubMed Link
Kistowska M et al. Dysregulation of the host mevalonate pathway during early bacterial infection activates human TCR gamma delta cells. 2008 Eur. J. Immunol. pmid:18624305
pmid:18635753
pmid:18653353
Lüdke SM et al. Stable carbon isotope discrimination by human 3-hydroxy-3-methylglutaryl-coenzyme A reductase. 2008 J. Lipid Res. pmid:18669481
Laezza C et al. The anandamide analog, Met-F-AEA, controls human breast cancer cell migration via the RHOA/RHO kinase signaling pathway. 2008 Endocr. Relat. Cancer pmid:18676619
Oliveira KA et al. Simvastatin inducing PC3 prostate cancer cell necrosis mediated by calcineurin and mitochondrial dysfunction. 2008 J. Bioenerg. Biomembr. pmid:18679777
Pscheidt B and Glieder A Yeast cell factories for fine chemical and API production. 2008 Microb. Cell Fact. pmid:18684335
Kotti T et al. Biphasic requirement for geranylgeraniol in hippocampal long-term potentiation. 2008 Proc. Natl. Acad. Sci. U.S.A. pmid:18685105
Sando T et al. Cloning and characterization of mevalonate pathway genes in a natural rubber producing plant, Hevea brasiliensis. 2008 Biosci. Biotechnol. Biochem. pmid:18685207
Acharjee S and Welty FK Atorvastatin and cardiovascular risk in the elderly--patient considerations. 2008 Clin Interv Aging pmid:18686752
Sławińska A and Kandefer-Szerszeń M [The anticancer properties of statins]. 2008 Postepy Hig Med Dosw (Online) pmid:18688209
pmid:18692592
Ness GC et al. Feedback regulation of hepatic 3-hydroxy-3-methylglutaryl-CoA reductase activity by dietary cholesterol is not due to altered mRNA levels. 1991 J. Biol. Chem. pmid:1869523
Begley M et al. Analysis of the isoprenoid biosynthesis pathways in Listeria monocytogenes reveals a role for the alternative 2-C-methyl-D-erythritol 4-phosphate pathway in murine infection. 2008 Infect. Immun. pmid:18765739
Kaliszewski P et al. Rsp5p ubiquitin ligase and the transcriptional activators Spt23p and Mga2p are involved in co-regulation of biosynthesis of end products of the mevalonate pathway and triacylglycerol in yeast Saccharomyces cerevisiae. 2008 Biochim. Biophys. Acta pmid:18771750
Anthony JR et al. Optimization of the mevalonate-based isoprenoid biosynthetic pathway in Escherichia coli for production of the anti-malarial drug precursor amorpha-4,11-diene. 2009 Metab. Eng. pmid:18775787
Habeos IG et al. Simvastatin activates Keap1/Nrf2 signaling in rat liver. 2008 J. Mol. Med. pmid:18787804
Bate C et al. Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells. 2008 BMC Biol. pmid:18789130
Baba TT et al. Simvastatin suppresses the differentiation of C2C12 myoblast cells via a Rac pathway. 2008 J. Muscle Res. Cell. Motil. pmid:18792797
Olson AL et al. Substrate induced structural and dynamics changes in human phosphomevalonate kinase and implications for mechanism. 2009 Proteins pmid:18798562
Voynova NE et al. Human mevalonate diphosphate decarboxylase: characterization, investigation of the mevalonate diphosphate binding site, and crystal structure. 2008 Arch. Biochem. Biophys. pmid:18823933
Sepp-Lorenzino L et al. Cell-cycle-dependent, differential prenylation of proteins. 1991 Eur. J. Biochem. pmid:1889420
Xiang Z and Reeves SA Simvastatin induces cell death in a mouse cerebellar slice culture (CSC) model of developmental myelination. 2009 Exp. Neurol. pmid:18929563
pmid:18941711
Domoki F et al. Rosuvastatin induces delayed preconditioning against oxygen-glucose deprivation in cultured cortical neurons. 2009 Am. J. Physiol., Cell Physiol. pmid:18971391
Vögeli U and Chappell J Inhibition of a plant sesquiterpene cyclase by mevinolin. 1991 Arch. Biochem. Biophys. pmid:1898013
Kimura T et al. Induction of scavenger receptor class B type I is critical for simvastatin enhancement of high-density lipoprotein-induced anti-inflammatory actions in endothelial cells. 2008 J. Immunol. pmid:18981156
Sapir-Mir M et al. Peroxisomal localization of Arabidopsis isopentenyl diphosphate isomerases suggests that part of the plant isoprenoid mevalonic acid pathway is compartmentalized to peroxisomes. 2008 Plant Physiol. pmid:18988695
Winegar DA et al. Isoprenylation of rap2 proteins in platelets and human erythroleukemia cells. 1991 J. Biol. Chem. pmid:1900292
Monzack EL et al. Efficacy of simvastatin treatment of valvular interstitial cells varies with the extracellular environment. 2009 Arterioscler. Thromb. Vasc. Biol. pmid:19023089
Kervizic G and Corcos L Dynamical modeling of the cholesterol regulatory pathway with Boolean networks. 2008 BMC Syst Biol pmid:19025648
García I et al. QSAR and complex network study of the chiral HMGR inhibitor structural diversity. 2009 Bioorg. Med. Chem. pmid:19026553
Balibar CJ et al. The mevalonate pathway of Staphylococcus aureus. 2009 J. Bacteriol. pmid:19028897
Sanford J et al. Gamma-subunits of G proteins, but not their alpha- or beta-subunits, are polyisoprenylated. Studies on post-translational modifications using in vitro translation with rabbit reticulocyte lysates. 1991 J. Biol. Chem. pmid:1903391
Rekittke I et al. Structure of (E)-4-hydroxy-3-methyl-but-2-enyl diphosphate reductase, the terminal enzyme of the non-mevalonate pathway. 2008 J. Am. Chem. Soc. pmid:19035630
pmid:19053515
pmid:19053857
Fujimoto M et al. Fluvastatin inhibits mast cell degranulation without changing the cytoplasmic Ca2+ level. 2009 Eur. J. Pharmacol. pmid:19059394
Farnsworth CC et al. C terminus of the small GTP-binding protein smg p25A contains two geranylgeranylated cysteine residues and a methyl ester. 1991 Proc. Natl. Acad. Sci. U.S.A. pmid:1906176
Mizuno T et al. A stimulatory GDP/GTP exchange protein for smg p21 is active on the post-translationally processed form of c-Ki-ras p21 and rhoA p21. 1991 Proc. Natl. Acad. Sci. U.S.A. pmid:1907371
pmid:19083230
Roitelman J et al. Involvement of calcium in the mevalonate-accelerated degradation of 3-hydroxy-3-methylglutaryl-CoA reductase. 1991 J. Biol. Chem. pmid:1908464
pmid:191001
Abumweis SS et al. Plant sterols/stanols as cholesterol lowering agents: A meta-analysis of randomized controlled trials. 2008 Food Nutr Res pmid:19109655
Schwartz YSh et al. Cholesterol-induced stimulation of postinflammatory liver fibrosis. 2008 Bull. Exp. Biol. Med. pmid:19110552
Lindemann CJ et al. Determination of mevalonolactone in capsules by capillary gas-liquid chromatography. 1991 J Pharm Biomed Anal pmid:1911983
Dje N'Guessan P et al. Statins control oxidized LDL-mediated histone modifications and gene expression in cultured human endothelial cells. 2009 Arterioscler. Thromb. Vasc. Biol. pmid:19122173
Deshpande G et al. Ggamma1, a downstream target for the hmgcr-isoprenoid biosynthetic pathway, is required for releasing the Hedgehog ligand and directing germ cell migration. 2009 PLoS Genet. pmid:19132091
Ohyama K et al. Dual biosynthetic pathways to phytosterol via cycloartenol and lanosterol in Arabidopsis. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19139393
Rydgren T and Sandler S The protective effect of simvastatin against low dose streptozotocin induced type 1 diabetes in mice is independent of inhibition of HMG-CoA reductase. 2009 Biochem. Biophys. Res. Commun. pmid:19150339
Knight LA et al. Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assay. 2009 BMC Cancer pmid:19175937
Fujiyama A et al. S-farnesylation and methyl esterification of C-terminal domain of yeast RAS2 protein prior to fatty acid acylation. 1991 J. Biol. Chem. pmid:1917931
Cuthbert JA and Lipsky PE Negative regulation of cell proliferation by mevalonate or one of the mevalonate phosphates. 1991 J. Biol. Chem. pmid:1917936
Löw P et al. The mevalonate pathway in the bloodstream form of Trypanosoma brucei. Identification of dolichols containing 11 and 12 isoprene residues. 1991 J. Biol. Chem. pmid:1918042
Zeiser R et al. Regulation of different inflammatory diseases by impacting the mevalonate pathway. 2009 Immunology pmid:19191903
pmid:19198899
Kim WY et al. Statins decrease dendritic arborization in rat sympathetic neurons by blocking RhoA activation. 2009 J. Neurochem. pmid:19209406
pmid:19219049
Tsuruta H et al. High-level production of amorpha-4,11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coli. 2009 PLoS ONE pmid:19221601
Lin Y et al. Triterpenic Acids Present in Hawthorn Lower Plasma Cholesterol by Inhibiting Intestinal ACAT Activity in Hamsters. 2011 Evid Based Complement Alternat Med pmid:19228775
Lachmann HJ and Hawkins PN Developments in the scientific and clinical understanding of autoinflammatory disorders. 2009 Arthritis Res. Ther. pmid:19232070
Yeger-Lotem E et al. Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity. 2009 Nat. Genet. pmid:19234470
Niessen J et al. Human platelets express organic anion-transporting peptide 2B1, an uptake transporter for atorvastatin. 2009 Drug Metab. Dispos. pmid:19237515
Kinsella BT et al. Posttranslational modification of Ha-ras p21 by farnesyl versus geranylgeranyl isoprenoids is determined by the COOH-terminal amino acid. 1991 Proc. Natl. Acad. Sci. U.S.A. pmid:1924354
pmid:19254730
Maeda T and Horiuchi N Simvastatin suppresses leptin expression in 3T3-L1 adipocytes via activation of the cyclic AMP-PKA pathway induced by inhibition of protein prenylation. 2009 J. Biochem. pmid:19254925
Ledezma E et al. Potentiated cytotoxic effects of statins and ajoene in murine melanoma cells. 2009 Melanoma Res. pmid:19276863
Ellsworth JL et al. Evidence for sterol-independent regulation of low-density lipoprotein receptor activity in Hep-G2 cells. 1991 Biochem. J. pmid:1930137
Alvarez Y et al. Cyclooxygenase-2 induced by zymosan in human monocyte-derived dendritic cells shows high stability, and its expression is enhanced by atorvastatin. 2009 J. Pharmacol. Exp. Ther. pmid:19318593
Khan MA et al. Statins impair CD1d-mediated antigen presentation through the inhibition of prenylation. 2009 J. Immunol. pmid:19342651
pmid:19346993
pmid:19360315
Suzuki M et al. Complete blockage of the mevalonate pathway results in male gametophyte lethality. 2009 J. Exp. Bot. pmid:19363204
pmid:19384817
Sun X et al. Identified biosynthetic pathway of aspergiolide A and a novel strategy to increase its production in a marine-derived fungus Aspergillus glaucus by feeding of biosynthetic precursors and inhibitors simultaneously. 2009 Bioresour. Technol. pmid:19386490
Scoppola A et al. Quantitation of plasma mevalonic acid using gas chromatography-electron capture mass spectrometry. 1991 J. Lipid Res. pmid:1940620
Elmberger PG et al. Effects of pravastatin and cholestyramine on products of the mevalonate pathway in familial hypercholesterolemia. 1991 J. Lipid Res. pmid:1940625
Sillero MA et al. Synthesis of ATP derivatives of compounds of the mevalonate pathway (isopentenyl di- and triphosphate; geranyl di- and triphosphate, farnesyl di- and triphosphate, and dimethylallyl diphosphate) catalyzed by T4 RNA ligase, T4 DNA ligase and other ligases Potential relationship with the effect of bisphosphonates on osteoclasts. 2009 Biochem. Pharmacol. pmid:19414000
pmid:19414014
Rothwell C et al. Cholesterol biosynthesis modulation regulates dengue viral replication. 2009 Virology pmid:19419745
Raemer PC et al. Statins inhibit NK-cell cytotoxicity by interfering with LFA-1-mediated conjugate formation. 2009 Eur. J. Immunol. pmid:19424968
pmid:19428716
Kato S et al. Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase. 2010 J. Cell. Mol. Med. pmid:19432822
Epstein WW et al. Quantitation of prenylcysteines by a selective cleavage reaction. 1991 Proc. Natl. Acad. Sci. U.S.A. pmid:1946384
Li J et al. Reduced expression of the mevalonate pathway enzyme farnesyl pyrophosphate synthase unveils recognition of tumor cells by Vgamma9Vdelta2 T cells. 2009 J. Immunol. pmid:19494338
pmid:19508172
Mansouri H et al. Effects of gibberellic acid on primary terpenoids and delta-tetrahydrocannabinol in Cannabis sativa at flowering stage. 2009 J Integr Plant Biol pmid:19522814
Bełtowski J et al. Adverse effects of statins - mechanisms and consequences. 2009 Curr Drug Saf pmid:19534648
pmid:1953779
Montoya CJ et al. Antiretroviral effect of lovastatin on HIV-1-infected individuals without highly active antiretroviral therapy (The LIVE study): a phase-II randomized clinical trial. 2009 Trials pmid:19538732
Sidorkiewicz M et al. Mevalonate pathway modulation is associated with hepatitis C virus RNA presence in peripheral blood mononuclear cells. 2009 Virus Res. pmid:19540284
Hashimoto F and Hayashi H Identification of intermediates after inhibition of cholesterol synthesis by aminotriazole treatment in vivo. 1991 Biochim. Biophys. Acta pmid:1954238
Yoon HE and Yang CW Established and newly proposed mechanisms of chronic cyclosporine nephropathy. 2009 Korean J. Intern. Med. pmid:19543484
Perttilä J et al. OSBPL10, a novel candidate gene for high triglyceride trait in dyslipidemic Finnish subjects, regulates cellular lipid metabolism. 2009 J. Mol. Med. pmid:19554302
Kroll J et al. Establishment of a novel anabolism-based addiction system with an artificially introduced mevalonate pathway: complete stabilization of plasmids as universal application in white biotechnology. 2009 Metab. Eng. pmid:19558962
Minichsdorfer C and Hohenegger M Autocrine amplification loop in statin-induced apoptosis of human melanoma cells. 2009 Br. J. Pharmacol. pmid:19563533
Zeki AA et al. Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond. 2009 Am. J. Respir. Crit. Care Med. pmid:19608720
Yoshida T et al. Determination of key intermediates in cholesterol and bile acid biosynthesis by stable isotope dilution mass spectrometry. 2008 Anal Chem Insights pmid:19609389
Lorenzen W et al. Isoprenoids are essential for fruiting body formation in Myxococcus xanthus. 2009 J. Bacteriol. pmid:19617362
Yang Z et al. Synergistic actions of atorvastatin with gamma-tocotrienol and celecoxib against human colon cancer HT29 and HCT116 cells. 2010 Int. J. Cancer pmid:19626588